戻る Agenda
The New EudraVigilance System: One Year After
Session Chair(s)
Margaret Anne Walters
Deputy EU Qualified Person for Pharmacovigilance
Merck, Sharp & Dohme Ltd, United Kingdom
The New EudraVigilance System: One Year After
Speaker(s)
Experience with Reporting and Accessing ICSRs in EV
Margaret Anne Walters
Merck, Sharp & Dohme Ltd, United Kingdom
Deputy EU Qualified Person for Pharmacovigilance
NCA Perspective
Rory Littlebury
GlaxoSmithKline (GSK), United Kingdom
Head of PVSO and QPPV Office
Industry Experience with Signalling in EV
Christiane Michel, DrMed, MSC
Novartis Pharma AG, Switzerland
Global Head Safety Signal Detection
Panel Discussion
Gaby L. Danan, MD, PHD
GLD, France
Pharmacovigilance Expert